ICP
GILD icon

Interchange Capital Partners’s Gilead Sciences GILD Stock Holding History

Interchange Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,500
Closed -$139K – 308
2024
Q4 		$139K Hold
1,500
– – 0.05% 249
2024
Q3 		$126K Hold
1,500
– – 0.04% 259
2024
Q2 		$103K Buy
+1,500
New +$100K 0.04% 264
2023
Q2 		– Sell
-300
Closed -$24.9K – 174
2023
Q1 		$24.9K Buy
+300
New +$24.8K 0.01% 217

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Interchange Capital Partners's GILD Position: Q1 2026 in Review

Interchange Capital Partners reduced its Gilead Sciences (GILD) stake by 27% in Q1 2026, selling an estimated $155K and leaving 3,054 shares worth $380K. The position accounts for 0.12% of the portfolio, ranked #176.

Interchange Capital Partners first reported a position in GILD in Q4 2020 and has held it in 9 quarters since. The position peaked at $511K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Interchange Capital Partners held 3,054 shares of Gilead Sciences worth $380K as of Q1 2026.
  • Interchange Capital Partners sold 1,106 Gilead Sciences shares in Q1 2026, an estimated $155K.
  • Gilead Sciences made up 0.12% of Interchange Capital Partners's portfolio in Q1 2026, its #176 holding.
  • Interchange Capital Partners first reported a position in Gilead Sciences in Q4 2020 and has held it in 9 quarters since.
  • Interchange Capital Partners's Gilead Sciences position peaked at $511K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Interchange Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.